Cure for HIV/AIDS is under research and a lot of pharma companies are getting close and claims to find a cure. Biotron is the latest leading name from Australia whose analysis of their new drug has yielded great results. The pharma company is currently working on the clinical trials of its lead flagship drug BIT225 for HIV and the results have broken the stock market.
Biotron has completed phase 2 clinical trials on the new HIV drug and will now work on the next stages and find ways to mass-produce the same. If the efforts from Biotron are successful, we could very soon cure HIV and AIDS with their flagship drugs.